Evidence map›Paper›PMID 30872641›Full record

ArticleScientific reports2019

Rapid identification and phylogenetic classification of diverse bacterial pathogens in a multiplexed hybridization assay targeting ribosomal RNA.

Roby P Bhattacharyya, Mark Walker, Rich Boykin, Sophie S Son, Jamin Liu, Austin C Hachey, Peijun Ma, Lidan Wu, Kyungyong Choi, Kaelyn C Cummins and 12 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Total synthesis of himastatin.Science (New York, N.Y.) · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Roby P BhattacharyyaInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Mark WalkerInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Rich BoykinNanoString Technologies, Inc., 530 Fairview Ave N, Seattle, WA, 98109, USA.
Sophie S SonInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Jamin LiuInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.ORCID 0000-0001-6386-3709
Austin C HacheyInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Peijun MaInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Lidan WuInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.ORCID 0000-0003-3150-6170
Kyungyong ChoiResearch Laboratory of Electronics and Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139, USA.
Kaelyn C CumminsInfectious Diseases Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.
Maura BensonInfectious Diseases Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.
Jennifer SkerryMicrobiology Laboratory, Department of Pathology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.
Hyunryul RyuResearch Laboratory of Electronics and Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139, USA.ORCID 0000-0003-3645-1930
Sharon Y WongInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Marcia B GoldbergInfectious Diseases Division, Department of Medicine, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.
Jongyoon HanResearch Laboratory of Electronics and Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139, USA.
Virginia M PierceMicrobiology Laboratory, Department of Pathology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.
Lisa A CosimiInfectious Diseases Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.
Noam ShoreshInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Jonathan LivnyInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA.
Joseph BeechemNanoString Technologies, Inc., 530 Fairview Ave N, Seattle, WA, 98109, USA. jbeechem@nanostring.com.
Deborah T HungInfectious Disease and Microbiome Program, Broad Institute of Harvard and MIT, 415 Main St, Cambridge, MA, 02142, USA. hung@molbio.mgh.harvard.edu.

Funding

RNA based diagnostics for rapid pathogen identification and drug resistanceR01AI117043 · NIAID · BROAD INSTITUTE, INC. · PI HUNG, DEBORAH T · 2015 to 2019
$6.5M
Bioinformatic and functional analysis of antibiotic-responsive small non-coding RNAs in bacterial pathogensK08AI119157 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BHATTACHARYYA, ROBY PAUL · 2015 to 2018
$758k
NIAID NIH HHS K08 AI119157NIAID NIH HHS R01 AI117043
6 · The paper itself

Abstract

Rapid bacterial identification remains a critical challenge in infectious disease diagnostics. We developed a novel molecular approach to detect and identify a wide diversity of bacterial pathogens in a single, simple assay, exploiting the conservation, abundance, and rich phylogenetic content of ribosomal RNA in a rapid fluorescent hybridization assay that requires no amplification or enzymology. Of 117 isolates from 64 species across 4 phyla, this assay identified bacteria with >89% accuracy at the species level and 100% accuracy at the family level, enabling all critical clinical distinctions. In pilot studies on primary clinical specimens, including sputum, blood cultures, and pus, bacteria from 5 different phyla were identified.

Indexed as

BacteriaMycobacteriumNucleic Acid HybridizationPhylogenyRNA, Ribosomal, 16SStaphylococcus aureusRNA, Ribosomal, 16S

Identifiers

PMID30872641
PMCPMC6418090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.